Innovating Works

IGARLE

Activa
CARsen: Senolytic CAR T cells as novel therapeutic concept for solid tumors and senescence associated diseas... EBERHARD KARLS UNIVERSITAET TUEBINGEN tramitó un H2020: ERC-2020-STG The adoptive transfer of T cells expressing CD19-directed chimeric antigen receptors (CARs) has yielded remarkable efficacy in patients with...
2021-01-18 - 2026-12-31 | Financiado
PMSMatTrain: Novel Biomaterial based Device for the Treatment of Progressive MS An Integrated Pan European... UNIVERSITY OF GALWAY tramitó un H2020: H2020-MSCA-ITN-2018 PMSMatTrain is focusing on gaining a comprehensive understanding of the progressive (late degenerative phase) of multiple sclerosis (PMS) fr...
2019-04-09 - 2024-01-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.